World first as patient receives pioneering lung cancer vaccine

Researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC) are leading a groundbreaking international clinical trial to investigate a personalised cancer vaccine for the most common type of lung cancer. The team, which includes the Liverpool Clinical Trials Centre (LCTC), is studying a bespoke vaccine which is designed to target […] The post World first as patient receives pioneering lung cancer vaccine appeared first on News .